Dr. Lal PathLabs Ltd Share Price

Overview

Dr. Lal PathLabs Ltd share price is currently ₹1,871.14, up by ₹15.97 (0.86%) from its previous closing price of ₹1,855.17. The share price has gained 7.8% over the past month and declined -43.75% over the past year. The stock's 52-week low and high are ₹0.00 and ₹3,482.83, respectively. Dr. Lal PathLabs Ltd has a market capitalisation of ₹ 31,670.00 Cr. The share price was last updated on 24 Aug 2026, 02:54 PM IST.

Dr. Lal PathLabs Ltd
Dr. Lal PathLabs Ltd
LALPATHLAB
 0.00
 15.97
0.86%
Healthcare
 0.00(%)1D

Updated: 24 Aug 2026, 02:54:12 pm IST

Market Data

Open Price

 1,883.21

Prev. Close

 1,855.17
 1,869.41

Day Low

 1,883.21

Day High

 0.00

52 Week Low

 3,482.83

52 Week High

HealthcareHospital & Healthcare Services
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

57.88

Sector PE

42.03

PB Ratio

12.84

Sector PB

5.83

EPS

32.33

Dividend Yield

1.56

Today's Volume

109.497 K

5 Day Avg. Volume

176.559 K

PEG Ratio

-1.20

Market Cap.

₹ 31,670.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 50% at ₹5/Share
30-Jul-202630-Jul-2026
DividendsFinal Dividend of 40% at ₹4/Share
25-Jun-202626-Jun-2026
DividendsInterim Dividend of 35% at ₹3.5/Share
05-Feb-202605-Feb-2026
Bonus1:1
19-Dec-202519-Dec-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
HDFC Flexi Cap Fund - Growth41.78 Lac
41.78 Lac
no change
UTI Flexi Cap Fund - Regular Plan - IDCW25.73 Lac
25.41 Lac
(1.25%)
Aditya Birla Sun Life Flexi Cap Fund - Regular Plan - Growth18.31 Lac
20.00 Lac
(9.2%)
SBI Large & Midcap Fund - Regular Plan - IDCW13.00 Lac
13.00 Lac
no change
Nippon India Small Cap Fund - Growth12.91 Lac
12.91 Lac
no change

About Dr. Lal PathLabs Ltd 👋

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

News & Events

Frequently Asked Questions

What is the share price of Dr. Lal PathLabs Ltd?

What is the market cap of Dr. Lal PathLabs Ltd?

Should I buy Dr. Lal PathLabs Ltd stock now?

What is the 52 week high and low of Dr. Lal PathLabs Ltd?

Is the Dr. Lal PathLabs Ltd stock good to buy?

Is Dr. Lal PathLabs Ltd a good buy for the long term?

Is Dr. Lal PathLabs Ltd overvalued or undervalued?

What is the PE and PB ratio of Dr. Lal PathLabs Ltd?

Start Now